Skip to main content

Market Overview

12 Health Care Stocks Moving In Friday's Intraday Session

Share:

 

Gainers

  • Catabasis Pharmaceuticals (NASDAQ:CATB) stock moved upwards by 147.32% to $6.01 during Friday's regular session. Catabasis Pharmaceuticals's stock is trading at a volume of 214.8 million shares as of 12:31 EST. This is 4278.21% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $120.7 million.
  • Novavax (NASDAQ:NVAX) stock rose 61.92% to $217.0. Trading volume for this security as of 12:31 EST is 28.7 million, which is 681.08% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $14.5 billion.
  • Vaxart (NASDAQ:VXRT) stock rose 39.23% to $12.42. As of 12:31 EST, Vaxart's stock is trading at a volume of 32.7 million, which is 321.34% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $1.3 billion.
  • Aspira Womens Health (NASDAQ:AWH) shares increased by 26.95% to $9.89. The current volume of 1.8 million shares is 282.77% of Aspira Womens Health's average full-day volume over the last 100 days (last updated at 12:31 EST). The company's market cap stands at $1.0 billion.
  • Bellicum Pharmaceuticals (NASDAQ:BLCM) stock moved upwards by 26.04% to $4.84. Bellicum Pharmaceuticals's stock is trading at a volume of 7.0 million shares as of 12:31 EST. This is 1223.97% of its average full-day volume over the last 100 days. The company's market cap stands at $29.5 million.
  • Atea Pharmaceuticals (NASDAQ:AVIR) shares moved upwards by 25.8% to $74.4. As of 12:31 EST, this security is trading at a volume of 619.6K shares, making up 184.9% of its average full-day volume over the last 100 days. The company's market cap stands at $6.1 billion.

 

 

Losers

 

  • iRhythm Technologies (NASDAQ:IRTC) shares fell 42.1% to $145.34 during Friday's regular session. Trading volume for iRhythm Technologies's stock is 3.2 million as of 12:31 EST. This is 772.17% of its average full-day volume over the last 100 days. The company's market cap stands at $4.1 billion.
  • Outlook Therapeutics (NASDAQ:OTLK) shares fell 19.79% to $0.98. The current volume of 15.6 million shares is 1751.75% of Outlook Therapeutics's average full-day volume over the last 100 days (last updated at 12:31 EST). The market value of their outstanding shares is at $124.4 million.
  • Cancer Genetics (NASDAQ:CGIX) shares declined by 17.5% to $3.96. As of 12:31 EST, this security is trading at a volume of 802.5K shares, making up 105.72% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $16.1 million.
  • Adamis Pharmaceuticals (NASDAQ:ADMP) shares fell 17.5% to $1.16. Trading volume for this security as of 12:31 EST is 22.6 million, which is 143.69% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $108.1 million.
  • BiondVax Pharmaceuticals (NASDAQ:BVXV) shares decreased by 16.91% to $4.57. Trading volume for BiondVax Pharmaceuticals's stock is 1.4 million as of 12:31 EST. This is 135.17% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $52.6 million. As per the news, the Q3 earnings report came out yesterday.
  • Lianluo Smart (NASDAQ:LLIT) shares fell 15.41% to $8.44. As of 12:31 EST, Lianluo Smart's stock is trading at a volume of 3.2 million, which is 583.54% of its average full-day volume over the last 100 days. The company's market cap stands at $30.3 million.

 

 

 

Related Articles (ADMP + AVIR)

View Comments and Join the Discussion!

Posted-In: BZI-TFMIntraday Update Markets Movers

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com